106 related articles for article (PubMed ID: 6174138)
21. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Berkowitz RS; Goldstein DP
Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
[TBL] [Abstract][Full Text] [Related]
22. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of plasma tumor markers in germinal tumors of the testis].
Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
[TBL] [Abstract][Full Text] [Related]
24. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
Hussa RO
Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
[TBL] [Abstract][Full Text] [Related]
26. Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
Kaye SB; Bagshawe KD; McElwain TJ; Peckham MJ
Br J Cancer; 1979 Mar; 39(3):217-23. PubMed ID: 88952
[TBL] [Abstract][Full Text] [Related]
27. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
28. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
[TBL] [Abstract][Full Text] [Related]
30. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
31. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
32. Testicular germ cell tumours: should current classification be revised?
Parkinson C; Beilby JO
Invest Cell Pathol; 1980; 3(2):135-40. PubMed ID: 6155364
[TBL] [Abstract][Full Text] [Related]
33. Treatment of trophoblastic neoplasia at the Cancer Control Agency of British Columbia.
Boyes DA; Pankratz E; Galliford B; White GM; Fairey RN; Yuen BH
Can Med Assoc J; 1977 Oct; 117(7):753-6. PubMed ID: 198082
[TBL] [Abstract][Full Text] [Related]
34. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
35. Ultrasonic evaluation of trophoblastic disease and the response to chemotherapy.
Murao F; Takamori H; Aoki S; Hata K; Hata T; Takahashi K; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1137-42. PubMed ID: 3039021
[TBL] [Abstract][Full Text] [Related]
36. The role of color Doppler flow in the management of nonmetastatic gestational trophoblastic disease.
Tepper R; Shulman A; Altaras M; Goldberger S; Maymon R; Holzinger M; Beyth Y
Gynecol Obstet Invest; 1994; 38(1):14-7. PubMed ID: 7959318
[TBL] [Abstract][Full Text] [Related]
37. [When does chemotherapy of trophoblastic disease should be stopped?].
Kobayashi O; Matsui H; Takamizawa H
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2405-10. PubMed ID: 3033103
[No Abstract] [Full Text] [Related]
38. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
[TBL] [Abstract][Full Text] [Related]
39. Clinical and laboratory investigation of a virilized woman with placental-site trophoblastic tumor.
Nagelberg SB; Rosen SW
Obstet Gynecol; 1985 Apr; 65(4):527-34. PubMed ID: 2984618
[TBL] [Abstract][Full Text] [Related]
40. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole.
Matsui H; Iitsuka Y; Suzuka K; Seki K; Sekiya S
Hum Reprod; 2001 Jun; 16(6):1274-7. PubMed ID: 11387305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
